Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Sep 17, 2024 07:00 ET
Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications
Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced the publication of preclinical data from studies of...
Sep 17, 2024 07:00 ET
AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease
AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease Prescreening rate of Phase 2b ReTain trial triggers clinical development milestone payment in...
Sep 17, 2024 07:00 ET
Aclaris Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor for the Treatment of Moderate to Severe Atopic Dermatitis
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that the first patient has been dosed in Aclaris' Phase 2a clinical...
Sep 17, 2024 07:00 ET
ADMA Biologics Set to Join S&P SmallCap 600 Index
ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced it will join the S&P SmallCap 600 index, effective prior to...
Sep 17, 2024 07:00 ET
BioCryst and the pan-Canadian Pharmaceutical Alliance (pCPA) Successfully Complete Negotiations for ORLADEYO® (berotralstat), an Oral, Once-daily Therapy for the Prevention of Hereditary Angioedema At
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) for oral, once-daily PrORLADEYO® (berotralstat), which is approved in Canada for the...
Sep 17, 2024 07:00 ET
Century Announces Resumption of Normal Shipping Operations at Jamalco Refinery
Century Aluminum announced today the resumption of normal shipping operations at Jamalco’s Rocky Point port following the completion of Hurricane Beryl-related repairs to the port. “I want to thank our entire Jamalco team who rose to the occasion...
Sep 17, 2024 07:00 ET
Cullinan Therapeutics Receives Approval to Initiate its Global Phase 1 Clinical Trial of CLN-978 for the Treatment of Systemic Lupus Erythematosus
Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today received Human Research Ethics Committee (HREC) approval in Australia to initiate its global Phase 1 clinical...
Sep 17, 2024 07:00 ET
DAVIDsTEA Reports Financial Results for Second Quarter of Fiscal 2024
DAVIDsTEA Inc. (TSX-Venture: DTEA) (“DAVIDsTEA” or the “Company”), a leading tea merchant in North America, announced today its second quarter results for the period ended August 3, 2024. “We are pleased to report that DAVIDsTEA reached a key...
Sep 17, 2024 07:00 ET
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes and Ascensia Diabetes Care, a...
Sep 17, 2024 07:00 ET
HR Technology Conference & Exposition® to Unveil Industry’s Latest Products Next Week
Returning to Mandalay Bay in Las Vegas next week, the annual HR Technology Conference & Exposition® will spotlight hundreds of solution providers from September 24 – 26, 2024. This includes dozens of new products that will debut during the show,...
Sep 17, 2024 07:00 ET
Industry leaders to speak at Wood Mackenzie’s Carbon Capture, Utilization and Storage Conference 2024
PRESS RELEASE Industry leaders to speak at Wood Mackenzie’s Carbon Capture, Utilization and Storage Conference 2024 Join executives from ExxonMobil Low Carbon...
Sep 17, 2024 07:00 ET
Merit Medical Signs Agreement to Purchase Lead Management Portfolio from Cook Medical
Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced it has signed a definitive asset purchase agreement to purchase Cook Medical’s lead management portfolio for total cash consideration of...
Sep 17, 2024 07:00 ET
Steakholder Foods® Launches New Demonstration Center to Showcase 3D Printing Food Production
Steakholder Foods Ltd. (Nasdaq: STKH), a leading innovator in alternative proteins and 3D printing technologies, is excited to announce the opening of its first full-scale Demonstration Center. The state-of-the-art facility features live...
Sep 17, 2024 07:00 ET
Striim 5.0 Previews Cutting-Edge Real-Time Data and AI Capabilities for Modernization and GenAI Adoption at Big Data LDN
Striim, an industry leader in real-time data integration and streaming, is excited to announce the private preview launch of Striim 5.0, which will become generally available in the near future. As data volumes surge and data quality requirements...
Sep 17, 2024 07:00 ET
Telix Announces Cardinal Health as U.S. Commercial Distributor for Zircaix®
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has selected Cardinal Health, Inc. (NYSE: CAH, Cardinal Health) as a commercial radiopharmaceutical distributor to supply finished unit doses of its PET1 agent,...
Sep 17, 2024 07:00 ET
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced dosing of the first two patients in its Phase 1 clinical trial with its lead candidate,...
Sep 17, 2024 07:00 ET
Vigil Neuroscience Announces FDA Has Removed Partial Clinical Hold on VG-3927
Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) has...
Sep 17, 2024 07:00 ET
Xtract One Technologies Launches New Gateway: Weapons Detection for Customers with Laptops and Other Large Items
Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”), today announced the launch of Xtract One Gateway (“Gateway”), the Company’s latest AI-driven security solution, at GSX 2024 in Orlando, Florida from...
Sep 17, 2024 06:58 ET
Xometry Europe Gives Enterprise Customers More Options To Quote And Manage Complex, High-Volume Projects
Xometry, Inc., (NASDAQ: XMTR), the global AI-powered marketplace connecting enterprise buyers with suppliers of manufacturing services, today unveiled a suite of new tools that make it even easier for enterprise customers to order parts for their...
Sep 17, 2024 06:45 ET
‘MADE in NJ’ Manufacturing Day 2024 Finalists Announced: Celebrating Excellence in Innovation and Leadership in New Jersey’s Manufacturing Industry
The New Jersey Manufacturing Extension Program (NJMEP) is proud to announce the finalists for the highly anticipated ‘MADE in NJ’ Manufacturing Day 2024. This annual event honors the achievements of outstanding manufacturing companies and...